论文信息 - Abstract A250: Preclinical combination efficacy and identification of biomarkers of MEK and PI3K inhibitors in phase I - 字舞流文

Abstract A250: Preclinical combination efficacy and identification of biomarkers of MEK and PI3K inhibitors in phase I

M. Belvin | K. Hoeflich | H. Koeppen | L. Friedman | J. Chan | L. Berry | M. Merchant | E. Chan | C. Orr | I. Chan | D. D. Otter | John Prescott